AI Article Synopsis
- Skin ulcers in patients with systemic sclerosis can be severely painful and challenging to treat.
- A case study shows that using becaplermin gel along with oral immunosuppressive agents effectively treats these ulcers, with healing times around 3 months.
- The treatment's success was comparable to other oral medications and specialized surgical options, with no major surgeries needed except for a biopsy.
Article Abstract
Skin ulcers can be very painful and detrimental in patients with systemic sclerosis, or systemic scleroderma. A brief review of scleroderma skin ulcers is presented, as well as a case study that demonstrates the effectiveness of becaplermin gel supplemented by oral immunosuppressive agents in the treatment of ulcers resulting from systemic sclerosis. The time to healing (approximately 3 months) was comparable to that associated with the oral agents and surgical interventions specifically designed to help heal scleroderma ulcers. Except for incisional biopsy, no surgical procedures were performed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.7547/87507315-92-6-350 | DOI Listing |
Publication Analysis
Top Keywords
skin ulcers
12
scleroderma skin
8
becaplermin gel
8
systemic sclerosis
8
ulcers
5
treatment scleroderma
4
ulcers becaplermin
4
gel hydrocolloid
4
hydrocolloid membrane
4
membrane skin
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!